Oxford Nanopore has announced that Tim Cowper is taking the role of Chief Financial Officer, and Jordan Herman has joined as General Counsel. “We’re delighted to announce that Tim will be taking on the important role of CFO, and to welcome Jordan to the Company after working with him for so long as external counsel,” […]
CAMBRIDGE, UK – EVONETIX LTD (‘Evonetix’), the synthetic biology company developing a desktop platform for scalable, high-fidelity and rapid gene synthesis, today announced the appointment of Michael Daniels, PhD, as Head of Product Management. In this role, Dr Daniels will be focused on the development and introduction of Evonetix’s first product, a DNA desktop writer. He will […]
MOUNTAIN VIEW, Calif. — DNAnexus, Inc., the leading cloud-based SaaS company serving the global Healthcare and Life Sciences community, today announced the promotion of Fan Fan, Ph.D., to Chief Product Officer. Dr. Fan will be responsible for driving the continued innovation and strategy for the company’s market-leading cloud platform for scientific analysis and collaboration. “Fan […]
CAMBRIDGE, England — Genestack Ltd. today announced that its flagship multi-omics data catalog, curation and integrative search product, Omics Data Manager (ODM), has been licensed and implemented by the Dutch vegetable breeding firm Bejo. Bejo anticipates that the Genestack modules, by providing a single source of truth for integrated multi-omics data, together with metadata management […]
This certification further demonstrates NEB’s commitment to environmental stewardship, scientific advancement and social responsibility as a global life science leader. IPSWICH, MA — New England Biolabs (NEB®), a leader in the discovery and production of enzymes for molecular biology applications, today announced it has become a Certified B Corporation™ (B Corp™), joining a global community […]
This certification further demonstrates NEB’s commitment to environmental stewardship, scientific advancement and social responsibility as a global life science leader. IPSWICH, MA — New England Biolabs (NEB®), a leader in the discovery and production of enzymes for molecular biology applications, today announced it has become a Certified B Corporation™ (B Corp™), joining a global community […]
CRISPRi Innovations Provide Expanded Experimental Options and Flexibility For Researchers Facilitating Disease & Drug Research WALTHAM, Mass. — Horizon Discovery, a PerkinElmer, Inc. (NYSE:PKI) company, today announced that its gene editing and modulation portfolio is expanding to include a new family of CRISPR modulation (CRISPRmod) reagents for CRISPR interference (CRISPRi). CRISPRi enables scientists to better understand the biological pathways, […]
Innovative qPCR platform simplifies molecular diagnostic workflows for infectious disease, oncology and COVID-19 testing CARLSBAD, Calif. — Thermo Fisher Scientific today announced the completion of the U.S. Food and Drug Administration (FDA) listing for the Applied Biosystems QuantStudio 5 Dx Real-Time PCR System. The innovative product enables clinical laboratories and assay developers to meet testing demands and enhance […]
Multi-year study will use Congenica’s platform for rapid and accurate genomic analysis Sioux Falls, South Dakota, United States and Cambridge, UK – Sanford Health (‘Sanford’), a leading US-based healthcare delivery system provider and Congenica, the digital health company enabling rapid and accurate analysis of complex genomic data to transform peoples’ lives, today announce a genomics partnership focused on […]
NEW YORK — Avista Capital Partners (“Avista”), a leading private equity firm focused exclusively on healthcare, today announced that it has signed a definitive agreement to invest in eMolecules (“eMolecules,” or the “Company”), a novel and fast-growing e-procurement platform for high-value chemicals and bioreagents used by the leading pharmaceutical companies in drug discovery. Financial terms […]
Pay Invoice
Latest Blogs
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
